Bashan Dror
- SEC CIK
- 0001781450
In the past year, 1 open-market purchase filing worth $101.4K and no sales.
Current role at each company
- PLX Protalix BioTherapeutics, Inc.PRESIDENT AND CEOas of Sep 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $101.4K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$101.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bashan Dror as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 (view filing) | Dec 19 | 4 days | Bashan DrorPRESIDENT AND CEO | PPurchase | +56.0K | $1.81 | +$101.4K | +42.3%188.5K after | |
| Oct 20, 2023 (view filing) | Oct 19 | 1 day | Bashan DrorPRESIDENT AND CEO | PPurchase | +64.5K | $1.40 | +$90.5K | +94.9%132.5K after | 2 lots |
| Apr 13, 2022 (view filing) | Apr 11 | 2 days | Bashan DrorPresident and CEO | PPurchase | +68.0K | $1.50 | +$102.0K | New position68.0K after |